Researchers found that, over 8 years, MRSA health care-associated infection rates significantly declined.
The use of prophages can reduce invasiveness in S aureus infections of diabetic foot ulcers that limit intracellular growth.
Community-acquired Staphylococcus aureus bacteremia risk rose along with the dosage.
During study period, decrease noted in S. aureus susceptibility to clindamycin.
Risk up seven-fold among patients with type 1 diabetes, almost three-fold for those with type 2.
Higher clinical cure rate compared with placebo in setting in which MRSA was prevalent.
Daily review of prescriptions linked to reduction in time to administer effective antimicrobials.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Antibiotic-Resistant Bacteria Have Long Resided on Ready-to-Eat Foods
- Infections Complicate Biologic Use in Autoimmune Inflammatory Disorders
- Tuberculosis Vaccine May Reverse Type 1 Diabetes
- No Benefits Seen for Adjunctive Clindamycin in Cellulitis
- Telbivudine During Early Pregnancy Prevents HBV Transmission
- Maternal Antibodies Hinder Antigenic Responses to Vaccines in Infants
- Sepsis-Related Mortality Decreased With Rapid Implementation of Protocol
- New Assay Targets Susceptibility to Ciprofloxacin in Gonorrhea
- Gut Microbiota Associated With Parkinson's Disease Progression
- Decrease Rate of S aureus Resistance Seen With Certain Antibiotics